But the tools and software that have been labelled as such have not been expansive – albeit they are biology centric. These tools have been focused on very specific areas such as peptide and oligonucleotide analysis – predicting things based on a sequence, alignment of sequences, etc.

However, in the past few years we have seen the combination of cloud technology, new biology techniques and, importantly, the rapid growth of biological entity therapeutics – macromolecules, eg MABs, FABS, RNA, large protein, Antibody Drug Conjugates (ADCs) – drive innovation in the provision of tools to support this diverse science and move far beyond the .........

You just need to REGISTER - its FREE - to read the rest of this article straight away.